These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation. West SK, Zambrano AI, Sharma S, Mishra SK, Muñoz BE, Dize L, Crowley K, Gaydos CA, Rotondo LA. JAMA Ophthalmol; 2017 Nov 01; 135(11):1141-1146. PubMed ID: 28973295 [Abstract] [Full Text] [Related]
4. Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district. Odonkor M, Naufal F, Munoz B, Mkocha H, Kasubi M, Wolle M, West S. PLoS Negl Trop Dis; 2021 Apr 01; 15(4):e0009343. PubMed ID: 33861754 [Abstract] [Full Text] [Related]
6. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program. Pant BP, Bhatta RC, Chaudhary JS, Awasthi S, Mishra S, Sharma S, Cuddapah PA, Gwyn SE, Stoller NE, Martin DL, Keenan JD, Lietman TM, Gaynor BD. PLoS Negl Trop Dis; 2016 Feb 01; 10(2):e0004462. PubMed ID: 26871898 [Abstract] [Full Text] [Related]
7. Serological Responses to Trachoma Antigens prior to the Start of Mass Drug Administration: Results from Population-Based Baseline Surveys, North Darfur, Sudan. Sanders AM, Elshafie BE, Abdalla Z, Simmons C, Goodhew EB, Gonzalez TA, Nute AW, Mohammed A, Callahan EK, Martin DL, Nash SD. Am J Trop Med Hyg; 2024 Sep 03; 111(3_Suppl):49-57. PubMed ID: 38507810 [Abstract] [Full Text] [Related]
8. Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana. Senyonjo L, Addy J, Martin DL, Agyemang D, Yeboah-Manu D, Gwyn S, Marfo B, Asante-Poku A, Aboe A, Mensah E, Solomon AW, Bailey RL. PLoS Negl Trop Dis; 2021 Sep 03; 15(9):e0009744. PubMed ID: 34543293 [Abstract] [Full Text] [Related]
9. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa. Last AR, Burr SE, Harding-Esch E, Cassama E, Nabicassa M, Roberts CH, Mabey DCW, Holland MJ, Bailey RL. Parasit Vectors; 2017 Dec 28; 10(1):624. PubMed ID: 29282126 [Abstract] [Full Text] [Related]
11. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger. Kim JS, Oldenburg CE, Cooley G, Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Keenan JD, Gaynor BD, Porco TC, Lietman TM, Martin DL. PLoS Negl Trop Dis; 2019 Jan 28; 13(1):e0007127. PubMed ID: 30689671 [Abstract] [Full Text] [Related]
12. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey. West SK, Munoz B, Weaver J, Mrango Z, Dize L, Gaydos C, Quinn TC, Martin DL. PLoS Negl Trop Dis; 2016 Jan 28; 10(1):e0004352. PubMed ID: 26771906 [Abstract] [Full Text] [Related]
16. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem. Senyonjo LG, Debrah O, Martin DL, Asante-Poku A, Migchelsen SJ, Gwyn S, deSouza DK, Solomon AW, Agyemang D, Biritwum-Kwadwo N, Marfo B, Bakajika D, Mensah EO, Aboe A, Koroma J, Addy J, Bailey R. PLoS Negl Trop Dis; 2018 Dec 28; 12(12):e0007027. PubMed ID: 30550537 [Abstract] [Full Text] [Related]
17. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children. Lee JS, Muñoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK. PLoS Negl Trop Dis; 2014 Apr 28; 8(4):e2761. PubMed ID: 24722392 [Abstract] [Full Text] [Related]
18. Changes in trachoma indicators in Kiribati with two rounds of azithromycin mass drug administration, measured in serial population-based surveys. Goodhew EB, Taoaba R, Harding-Esch EM, Gwyn SE, Bakhtiari A, Butcher R, Cama A, Guagliardo SAJ, Jimenez C, Mpyet CD, Tun K, Wickens K, Solomon AW, Martin DL, Tekeraoi R. PLoS Negl Trop Dis; 2023 Jul 28; 17(7):e0011441. PubMed ID: 37418501 [Abstract] [Full Text] [Related]
19. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics. Ervin AM, Mkocha H, Munoz B, Dreger K, Dize L, Gaydos C, Quinn TC, West SK. Ophthalmic Epidemiol; 2016 Dec 28; 23(6):347-353. PubMed ID: 27820670 [Abstract] [Full Text] [Related]
20. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R, Partnership for Rapid Elimination of Trachoma (PRET) study group. PLoS Negl Trop Dis; 2013 Dec 28; 7(6):e2115. PubMed ID: 23785525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]